Cargando…

Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant Staphylococcus aureus

The treatment and hospital-spread-control of methicillin-resistant Staphylococcus aureus (MRSA) is an important challenge since these bacteria are involved in a considerable number of nosocomial infections that are difficult to treat and produce prolonged hospitalization, thus also increasing the ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velázquez-Suárez, Cristina, Cebrián, Rubén, Gasca-Capote, Carmen, Sorlózano-Puerto, Antonio, Gutiérrez-Fernández, José, Martínez-Bueno, Manuel, Maqueda, Mercedes, Valdivia, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388780/ https://www.ncbi.nlm.nih.gov/pubmed/34438974 http://dx.doi.org/10.3390/antibiotics10080925

Ejemplares similares

Synergy of the Bacteriocin AS-48 and Antibiotics against Uropathogenic Enterococci
por: Montalbán-López, Manuel, et al.
Publicado: (2020)

Preclinical studies of toxicity and safety of the AS-48 bacteriocin
por: Cebrián, Rubén, et al.
Publicado: (2019)

Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme
por: Cebrián, Rubén, et al.
Publicado: (2018)

Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48
por: Martínez-García, Marta, et al.
Publicado: (2018)

Insights into Chagas treatment based on the potential of bacteriocin AS-48
por: Martín-Escolano, Rubén, et al.
Publicado: (2019)

LAB Bacteriocins Controlling the Food Isolated (Drug-Resistant) Staphylococci
por: Perales-Adán, Jesús, et al.
Publicado: (2018)

Analysis of the Promoters Involved in Enterocin AS-48 Expression
por: Cebrián, Rubén, et al.
Publicado: (2014)

Advances in the preclinical characterization of the antimicrobial peptide AS-48
por: Cebrián, Rubén, et al.
Publicado: (2023)

Synergistic Inhibition by Bacteriocin and Bacteriophage against Staphylococcus aureus
por: Kim, Seon-Gyu, et al.
Publicado: (2019)

Novel Cytoplasmic Bacteriocin Compounds Derived from Staphylococcus epidermidis Selectively Kill Staphylococcus aureus, Including Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Jang, In-Taek, et al.
Publicado: (2020)

Determination of the effect of the bacteriocin enterocin AS-48 on the microbial loads and bacterial diversity of blueberries
por: Rodríguez López, Javier, et al.
Publicado: (2023)

Staphylococcal-Produced Bacteriocins and Antimicrobial Peptides: Their Potential as Alternative Treatments for Staphylococcus aureus Infections
por: Newstead, Logan L., et al.
Publicado: (2020)

Evaluating the Translational Potential of Bacteriocins as an Alternative Treatment for Staphylococcus aureus Infections in Animals and Humans
por: Heinzinger, Lauren R., et al.
Publicado: (2023)

Multidrug Efflux Pumps in Staphylococcus aureus: an Update
por: Costa, Sofia Santos, et al.
Publicado: (2013)

The Role of Key Amino Acids in the Antimicrobial Mechanism of a Bacteriocin Model Revealed by Molecular Simulations
por: Cruz, Víctor L., et al.
Publicado: (2021)

Effectiveness of raw bacteriocin produced from lactic acid bacteria on biofilm of methicillin-resistant Staphylococcus aureus
por: Ibraheim, Hanaa Khaleel, et al.
Publicado: (2023)

Multidrug-Resistant Staphylococcus aureus in US Meat and Poultry
por: Waters, Andrew E., et al.
Publicado: (2011)

Multidrug-Resistant Staphylococcus aureus, India, 2013–2015
por: Kumar, Mohit
Publicado: (2016)

Repurposing Eltrombopag for Multidrug Resistant Staphylococcus aureus Infections
por: Lee, Hyunjung, et al.
Publicado: (2021)

Genomic analyses of pneumococci reveal a wide diversity of bacteriocins – including pneumocyclicin, a novel circular bacteriocin
por: Bogaardt, Carlijn, et al.
Publicado: (2015)

Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91
por: Wladyka, Benedykt, et al.
Publicado: (2012)

Screening, purification and characterization of thermostable, protease resistant Bacteriocin active against methicillin resistant Staphylococcus aureus (MRSA)
por: Ansari, Asma, et al.
Publicado: (2018)

Circular and Leaderless Bacteriocins: Biosynthesis, Mode of Action, Applications, and Prospects
por: Perez, Rodney H., et al.
Publicado: (2018)

Vancomycin modifies the expression of the agr system in multidrug-resistant Staphylococcus aureus clinical isolates
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

Identification of novel bacteriocin against Staphylococcus and Bacillus species
por: Aldarhami, Abdu
Publicado: (2023)

A Staphylococcus capitis strain with unusual bacteriocin production
por: Szekat, Christiane, et al.
Publicado: (2023)

Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus
por: Costa, Sofia Santos, et al.
Publicado: (2015)

Thermally triggered release of the bacteriophage endolysin CHAP(K) and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)
por: Hathaway, Hollie, et al.
Publicado: (2017)

A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms
por: Kranjec, Christian, et al.
Publicado: (2020)

In Vitro Antibacterial Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate Derived from Allium spp. against Gram-Negative and Gram-Positive Multidrug-Resistant Bacteria Isolated from Human Samples
por: Sorlozano-Puerto, Antonio, et al.
Publicado: (2018)

A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms
por: Kranjec, Christian, et al.
Publicado: (2021)

Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties
por: Corman, Hannah N., et al.
Publicado: (2022)

Household Risk Factors for Colonization with Multidrug-Resistant Staphylococcus aureus Isolates
por: Davis, Meghan F., et al.
Publicado: (2013)

Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus
por: Bravo-Santano, Natalia, et al.
Publicado: (2019)

Targeting the Achilles’ Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide
por: Sionov, Ronit Vogt, et al.
Publicado: (2022)

In Silico Analysis Highlights the Diversity and Novelty of Circular Bacteriocins in Sequenced Microbial Genomes
por: Xin, Bingyue, et al.
Publicado: (2020)

In vitro and in vivo production and split-intein mediated ligation (SIML) of circular bacteriocins
por: Peña, Nuria, et al.
Publicado: (2022)

Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing
por: Elmore, Bradley O., et al.
Publicado: (2015)

Three Distinct Two-Component Systems Are Involved in Resistance to the Class I Bacteriocins, Nukacin ISK-1 and Nisin A, in Staphylococcus aureus
por: Kawada-Matsuo, Miki, et al.
Publicado: (2013)

Polymicrobial Interactions Induce Multidrug Tolerance in Staphylococcus aureus Through Energy Depletion
por: Nabb, Dan L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hgvs1n6mq6ofmge75dv6b2tp29